California stem cell clinic to pay out $3.65M settlement to former patients for ineffective treatments
Four years after the FDA admonished stem cell clinic StemGenex for making dubious claims about its services in treating incurable diseases, and 3 years after the company first filed for bankruptcy, the clinic and its former CMO seem to have reached their final destination: a $3.65 million bill in a class action settlement.
Federal judge Anthony Battaglia in San Diego gave final approval to the deal in late February, with the insurance carriers for the now-dead clinic along with StemGenex’s former CMO and osteopath Andre Lallande footing the bill and paying 1,063 former clients. The insurance for the clinic will pay $1.15 million, and the insurer for Lallande, a rheumatologist, will pay $2.5 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.